<xmp id="aecc8"><nav id="aecc8"></nav>
<nav id="aecc8"><code id="aecc8"></code></nav>
<tt id="aecc8"><tt id="aecc8"></tt></tt>
<dd id="aecc8"></dd>
  • <dd id="aecc8"></dd>
    86-311-87881081 Chinese
    Location:Home > News > Company

    Bio-High establish a research and development centre in Hong Kong

    Time:2020-03-03 10:45:16 Click:

    On April 10,2019, the theme of "Sharing New Opportunities for National Strategy ? Creating a New Chapter of Cooperation between Hong Kong and Hebei ", hosted by the Hebei Provincial Government, was presented at the Hong Kong Convention and Exhibition Centre. The enterprise and the Hong Kong merchant carry on the project docking ahead of time, carries on the negotiation cooperation in depth.

    Bio-High Hong Kong Research and Development Centre in Hebei Province as the only Hong Kong investment project. With the testimony of Governor Xu Qin of Hebei Province, Chief Executive of the Hong Kong Special Administrative Region, Mrs Carrie Lam, Director of the China Joint Liaison Office, Mr Stephen Green, and Commissioner of the Ombudsman's Office of the Ministry of Foreign Affairs in Hong Kong, Mr Xie Feng, the cooperation agreement was signed with the Hong Kong partners.


    20200303771031.png


    Bio-High Hong Kong Research and Development Centre Project to change Hong Kong's previous practice of exporting funds and technology to the Mainland, Instead of exporting technology from Hebei to Hong Kong to achieve complementary advantages, Hebei companies boldly "go out ",implementing national innovation-driven development strategies. 

    Bio-High Hong Kong Research and Development Centre will rely on Hong Kong's unique geographical advantages, build strategic partners with international professional bodies and talent using international market and international resource advantages, Jointly strengthen the research and development of new drugs for tumor targeting and accelerate the progress,rapidly cultivating the international leading edge in the field of "new drugs for tumor targeting" accelerating the completion of clinical trials and promotion.

     


    Copyright Hebei Bio-High Technology Development CO.,LTD Website:bcitb.com
    购彩助手